Aktiesnakken — November 2010
-
jamen i forhold til genmab?, neurosearch? og med deres time to market?
-
Heidelberg skal de ikke byde lidt på H+H
-
ja og her sidder jeg og venter på deres kvartalsregnskab....
-
jeg vil bare sikrer mig at de skal ud i en kapitalrejsning og at den strategi de har fremlagt også folder sig ud.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind